The Company
Who we are
NanoLockin
NanoLockin is an early-stage startup company developing instruments for the detection and analysis of nanoparticles in all kinds of products. As a spin-off from the Adolphe Merkle Institute - an institution which specializes on nanomaterials research - the team of NanoLockin has long lasting expertise in the analysis of nanomaterials.
Meet our Team
Founded in 2018 by four people, our team currently exists of the following people.
Dr Christoph Geers
CEO & Co-founder
Christoph is responsible for the technical, application and business development. He has a strong technical background in a variety of different fields (Biotechnology, Chemistry, Material Sciences & Biomedical Engineering) and is highly experienced in the field of nanoparticle analytics.
Prof Dr Gunter Festel
Co-Founder
Gunter supports the CEO in all business-related aspects like business development and the acquisition of financial resources. Gunter has a deep understanding of scientific and business aspects due to 20 years of experience in technology development, both in big companies and startups.
Advisory Board
To help us on our journey, we are very happy to have the following world-class experts in our advisory board.
Prof Dr Alke Fink
Scientific Advisor
Prof. Fink is a chemist by training and a leading materials scientist in the field of modern nanotechnologies. With 15 years of experience in the synthesis and characterization of engineered nanoparticles, numerous national and international academic and industrial projects, and the training of more than 50 PhD students, post-doctoral researchers, senior scientists etc. Prof. Fink has built up a strong international network with both, academia and to industry.
Prof Dr Barbara Rothen-Rutishauser
Scientific Advisor
Prof. Rothen-Rutishauser is a leading scientist in the field of nanoparticle hazard and risk assessment, with a background in cell biology. She is a pioneer in the field of the next generation development of in vitro alternatives to study the interaction of NPs with human tissues. She has a proven track record of successful collaborations with implementation partners, ranging from regulatory bodies, federal agencies to industry partners. The engagement in application-oriented research has been recognized and funded by numerous grants as well as with several prestigious prices.
Peter Lack
Technology Advisor
Peter supports the CEO in technical related aspects regarding the transfer from prototype to industrial production. Peter has more than 28 years of experience in industrial manufacturing with a deep knowledge of highly automation in the fields injection, stamping and automatic assembling.